Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axim Biotechnologies is a clinical-stage biotechnology company primarily focused on the development of cannabinoid-based pharmaceutical products and innovative diagnostic solutions. The company is well-known for its proprietary MedChew Rx delivery system, a functional chewing gum designed to provide controlled release of cannabinoids for indications such as multiple sclerosis and pain management. In recent years, Axim has expanded its portfolio into the diagnostics sector, developing rapid point-of-care tests for dry eye disease and COVID-19 antibodies. Headquartered in San Diego, the company aims to address unmet medical needs through unique delivery methods and accessible diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axim Pharmaceuticals.